Tracon Pharmaceuticals Inc Expected To Post A Loss Of 31 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

09/08/2021 23:00

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show a no change in quarterly revenue when it reports
results on August 11. 
​* Refinitiv's mean analyst estimate for TRACON Pharmaceuticals
Inc is for a loss of 31 cents per share. For the same quarter
last year, the company reported a loss of 70 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $13​, about 70.9% above​ its last closing
price of $3.78. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.30       -0.30      -0.33     Missed  -8.2
 Dec. 31 2020  -0.44       -0.41      -0.31     Beat    23.6
 Sep. 30 2020  -0.64       -0.65      -0.38     Beat    41.5​
 Jun. 30 2020  -0.73       -0.73      -0.70     Beat    3.7
 Mar.          -1.12​      -1.13      -0.78     Beat    31.1​
 31​ 2020​                                              
 Dec. 31 2019  -1.65       -1.66      -1.25     Beat    24.9​
 Sep. 30 2019  -2.07       -2.05      -1.70     Beat    17.1
 Jun. 30 2019  -1.96       -1.90      -2.10     Missed  -10.5
 This summary was machine generated August 9 at 22:00 GMT.  All
figures in US dollars unless otherwise stated